REVERSING DIABETES: ROUNDTABLE WITH HEALTHCARE LEADERS TURNED PATIENTS
April 17, 2019 | (3:30 PM)
USA (United States of America)
Health plans and employers spend $16,000+ per year on average for each member living with Type 2 Diabetes (T2D)-- 4x the costs for a non-diabetic member. Meanwhile, predominating fee-for-service healthcare reimbursement models continue to incentivize management and medication over reversing the disease. To meet payers’ needs for more effective solutions that reduce their populations’ growing T2D prevalence and dependence on expensive medications, new value-based care models are emerging that spur clinically meaningful health outcomes and cost savings.